Literature DB >> 27119465

Current options for the treatment of pathological scarring.

Julian Poetschke1, Gerd G Gauglitz1.   

Abstract

Scarring is the consequence of surgery, trauma or different skin diseases. Apart from fresh, immature scars,that transform into mature scars over the course of would healing and that do not require further treatment,linear hypertrophic scars, widespread hypertrophic scars, keloids and atrophic scars exist. Symptoms like pruritusand pain, stigmatization as well as functional and aesthetic impairments that are very disturbing for the affected patients can bethe basis for the desire for treatment. Today, a multitude of options for the treatment and prevention of scars exists. Topical agents based on silicone or onion extract, intralesional injections of cristalline glucocorticoids (oftentimes in combinationwith cryotherapy) or 5-Fluorouracil as well as ablative and nonablative laser treatment are used. Current guidelines summarize the multitude of available treatment options and the currently available datafor the treating physicians, allowing them to make clear therapy recommendations for every single scar type. Relieving patients of their discomfort and doing their aesthetic demands justice is thus possible. Apart from scar prevention becoming more and more important, the increased use of modernlaser treatment options constitutes a key point in clinical scar treatment. At the same time the attention is turned to evaluating current therapeutic options with the help of contemporary study designs so as to graduallyimprove the level of evidence in scar treatment.
© 2016 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27119465     DOI: 10.1111/ddg.13027

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  8 in total

1.  Objective evaluation of the efficacy of a non-ablative fractional 1565 nm laser for the treatment of deliberate self-harm scars.

Authors:  Anne Guertler; Markus Reinholz; Julian Poetschke; Stephanie Steckmeier; Hannah Schwaiger; Gerd G Gauglitz
Journal:  Lasers Med Sci       Date:  2017-10-27       Impact factor: 3.161

2.  Combination Therapy Using Radiofrequency Microneedling and Corticosteroids for Hypertrophic Scars: A Case Report.

Authors:  Margit Juhasz; Nathan Fackler; Christine Pham; Natasha Atanaskova Mesinkovska
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

Review 3.  [Therapy of scars with lasers].

Authors:  G G Gauglitz; J Pötschke; M T Clementoni
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

4.  Pirfenidone inhibits epithelial-mesenchymal transition in keloid keratinocytes.

Authors:  Latha Satish; Alexander Evdokiou; Eleni Geletu; Jennifer M Hahn; Dorothy M Supp
Journal:  Burns Trauma       Date:  2020-02-27

5.  Topical 5 fluorouracil cream vs combined 5 fluorouracil and fractional erbium YAG laser for treatment of severe hypertrophic scars.

Authors:  Abeer Attia Tawfik; Maha Fathy; Ashraf Badawi; Noha Abdallah; Hisham Shokeir
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-03-14

6.  Management of keloid scars: noninvasive and invasive treatments.

Authors:  Sang Wha Kim
Journal:  Arch Plast Surg       Date:  2021-03-15

Review 7.  Current Therapeutic Approach to Hypertrophic Scars.

Authors:  Zrinka Bukvić Mokos; Anamaria Jović; Lovorka Grgurević; Ivo Dumić-Čule; Krešimir Kostović; Romana Čeović; Branka Marinović
Journal:  Front Med (Lausanne)       Date:  2017-06-20

Review 8.  The Role of Extracellular Matrix in Skin Wound Healing.

Authors:  Nikolai N Potekaev; Olga B Borzykh; German V Medvedev; Denis V Pushkin; Marina M Petrova; Artem V Petrov; Diana V Dmitrenko; Elena I Karpova; Olga M Demina; Natalia A Shnayder
Journal:  J Clin Med       Date:  2021-12-18       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.